Natixis Advisors LLC cut its stake in shares of Houlihan Lokey, Inc. (NYSE:HLI - Free Report) by 7.1% in the 3rd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 325,374 shares of the financial services provider's stock after selling 24,893 shares during the period. Natixis Advisors LLC owned 0.46% of Houlihan Lokey worth $66,806,000 at the end of the most recent quarter.
A number of other institutional investors also recently made changes to their positions in the company. Mayflower Financial Advisors LLC bought a new stake in Houlihan Lokey in the 3rd quarter valued at $230,335,000. ING Groep NV bought a new position in Houlihan Lokey during the 3rd quarter worth $4,640,000. Thrivent Financial for Lutherans increased its position in Houlihan Lokey by 75.6% during the 3rd quarter. Thrivent Financial for Lutherans now owns 713,494 shares of the financial services provider's stock worth $146,495,000 after buying an additional 307,214 shares during the period. Baker Ellis Asset Management LLC acquired a new stake in shares of Houlihan Lokey during the third quarter worth $589,000. Finally, Geneos Wealth Management Inc. lifted its holdings in shares of Houlihan Lokey by 63.2% during the second quarter. Geneos Wealth Management Inc. now owns 33,430 shares of the financial services provider's stock worth $6,016,000 after buying an additional 12,944 shares in the last quarter. Institutional investors own 78.07% of the company's stock.
Analyst Ratings Changes
Several research firms recently commented on HLI. UBS Group restated a "neutral" rating and issued a $196.00 price target on shares of Houlihan Lokey in a research note on Friday, January 30th. Keefe, Bruyette & Woods dropped their price objective on shares of Houlihan Lokey from $218.00 to $214.00 and set an "outperform" rating for the company in a research note on Thursday, January 29th. BMO Capital Markets boosted their price objective on shares of Houlihan Lokey from $209.00 to $211.00 and gave the company an "outperform" rating in a report on Thursday, January 29th. Weiss Ratings upgraded shares of Houlihan Lokey from a "hold (c+)" rating to a "buy (b-)" rating in a research report on Friday, February 20th. Finally, Morgan Stanley dropped their price target on shares of Houlihan Lokey from $216.00 to $215.00 and set an "overweight" rating for the company in a research report on Tuesday, January 6th. Five research analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company's stock. According to data from MarketBeat, Houlihan Lokey has an average rating of "Moderate Buy" and a consensus target price of $209.17.
Check Out Our Latest Stock Analysis on Houlihan Lokey
Insider Activity
In other Houlihan Lokey news, General Counsel Christopher M. Crain sold 500 shares of Houlihan Lokey stock in a transaction dated Friday, January 2nd. The stock was sold at an average price of $174.17, for a total value of $87,085.00. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Also, Director Robert A. Schriesheim sold 5,000 shares of the firm's stock in a transaction that occurred on Friday, February 6th. The shares were sold at an average price of $170.86, for a total transaction of $854,300.00. Following the completion of the sale, the director owned 27,982 shares in the company, valued at approximately $4,781,004.52. The trade was a 15.16% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Company insiders own 22.83% of the company's stock.
Houlihan Lokey Stock Down 3.8%
HLI stock opened at $151.32 on Monday. The company's 50-day moving average price is $173.75 and its two-hundred day moving average price is $183.91. The firm has a market cap of $10.56 billion, a P/E ratio of 23.24 and a beta of 0.95. Houlihan Lokey, Inc. has a 12 month low of $137.99 and a 12 month high of $211.78.
Houlihan Lokey (NYSE:HLI - Get Free Report) last posted its quarterly earnings results on Thursday, January 29th. The financial services provider reported $1.94 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.85 by $0.09. Houlihan Lokey had a net margin of 16.91% and a return on equity of 24.46%. Houlihan Lokey's revenue for the quarter was up 13.0% on a year-over-year basis. During the same quarter last year, the business posted $1.64 EPS. Equities analysts predict that Houlihan Lokey, Inc. will post 5.98 EPS for the current year.
Houlihan Lokey Dividend Announcement
The firm also recently disclosed a quarterly dividend, which will be paid on Sunday, March 15th. Investors of record on Monday, March 2nd will be given a dividend of $0.60 per share. This represents a $2.40 annualized dividend and a dividend yield of 1.6%. The ex-dividend date is Monday, March 2nd. Houlihan Lokey's dividend payout ratio is currently 36.87%.
Houlihan Lokey Company Profile
(
Free Report)
Houlihan Lokey, Inc is a global investment bank and financial services firm founded in 1972 and headquartered in Los Angeles, California. The company specializes in advisory services across a broad range of transaction types and financial matters. Since its founding, Houlihan Lokey has grown to serve corporations, financial sponsors, and government entities worldwide, providing expertise in complex and high-stakes engagements.
The firm's core service offerings include mergers and acquisitions advisory, capital markets advisory, financial restructuring and distressed M&A, and valuation and fairness opinions.
Featured Articles
Want to see what other hedge funds are holding HLI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Houlihan Lokey, Inc. (NYSE:HLI - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Houlihan Lokey, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Houlihan Lokey wasn't on the list.
While Houlihan Lokey currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
A forward-looking investment report spotlighting the seven space companies best positioned to benefit from accelerating commercialization in 2026. It explores key industry trends, major growth catalysts, and the stocks shaping the next phase of the space economy—from launch leaders and satellite networks to data, defense, and in-space infrastructure.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.